Exam 4 Flashcards
What is the other name for neuromuscular monitoring
Acceleromyography
most common location, nerve, and muscle monitored
abductor pollicis muscle, hand, ulnar nerve
NMBD Reversal Agents
edrophonium
neostigmine
Anti-Cholinergic Agents
atropine sulfate
glycopyrrolate
NMBD Reversal Agents MOA
AcetylcholineEsterase (AchE) Inhibitors, Cholinergic Agents, COMPETITIVE ANTAGONISTS
AchE: Rapid hydrolysis (catalyze) of Ach
Inhibition = more Acetylcholine available
Ach binds to alpha subunits;
Available @:
Preganglionic (SNS & PNS)
NMJ- main focus
Total max neostigmine dose
5mg
Neostigmine max range
40 to 70 mcg/kg
Edrophonium max range
1 mg/kg
NMBD Reversal Agents will not work with…..
Will not work with deep NM blockade
because of ceiling effect
Reversal of NM Blockade depends on 5 factors:
- Depth of the NM Block
- AchE Inhibitor choice
- Dose administered
- Rate of plasma clearance of NMBD
- Anesthesia agent choice and depth
What NMBD needs to be reconstituted w/ distilled water
Vec - reconsitiute w/ 10 ml to make 1 ml
Why is pancuronium given to cardiac patients?
INtrinsic effects on cardiac accelerators and good for the cardiac muscle
Goal of NMBD reversal agents
Prevent postoperative residual NM blockade
Sugammadex dose
2-16 mg/kg
Neostigmine onset
5-10 min
neostigmine duration
60 mins
Neostigmine anticholinergic
glycopyrrolate 0.2 mg/ml of neostigmine
Sugammadex onset
1-4 min
Sugammadex duration
1.5-3 hrs
sugammadex anticholinergic
none
Edrophonium onset
1-2 mins
Edrophonium duration
5-15 min
Pyridostigminge and edrophonium are excreted by how much renaly
75%
Overall side effects of NMBD reversal agents are a result from increased…..
Increased Nicotinic/Muscarinic Activity
How much neostigmine is excreted renaly
50%
30-50% hepatic if no renal function
CRF (chronic renal failure) does what to plasma clearance
decrease plasma clearance= prolonged action
Cardiac Side effect for nmbd reversal agents
Bradycardia, dysrhythmias, asystole, ↓SVR
Pulmonary Side effect for nmbd reversal agents
Bronchoconstriction, increased airway resistance, increased salivation
GI Side effect for nmbd reversal agents
Hyperperistalsis, enhanced gastric fluid secretion, PONV
Eyes Side effect for nmbd reversal agents
Miosis
Atropine side effect and matches….
side effects; mydriasis and initial tachycardia
matches profile of edrophonium
Atropine dose
7-10 mcg/kg
Glycopyrrolate matches the profile of….
Neostigmine and pyridostigmine
Glycopyrrolate dose
7-15 mcg/kg (1 mg max)
Anti-cholinergic/ anti muscarinic agents for cardiac disease
Glycopyrolate is preferred over atropine
to be administered slowly over 2-5 minutes
mechanism for persistent NM blockade
Acetylcholinesterase is maximally inhibited
No further anticholinesterase is effective
intervention for persistent nm blockade
sedation and postop ventilation
Sugammadex MOA
intermolecular (van der Walls) forces, thermodynamic (hydrogen) bonds, and hydrophobic interactions* -> reversal by encapsulation.
pull paralytic form nmj to the plasma
Binds to ‘free drug” in plasma**
Medications that sugammadex binds to
Rocuronium > Vecuronium»_space; Pancuronium (least), best with ROC
Sugammadex E1/2
2 hrs
Sugammadex Major route of elimination:
Urine
70% in 6 hours
90% in 24 hours
Renal impairment: C/I with dialysis by dialysis
Sugammadex facts
Selective Relaxant-Binding Agent
γ-cyclodextrin
dextrose units from starch
Highly water soluble= mainly excreted in the kidney
drug that does not need binding with glycopyrolate / atropine
sugammadex
Deep block sugammadex dose
1-2 post-tetanic counts but not twitch response = 4mg/kg
moderate sugammadex dose
2/4 twitches = 2mg/kg
Where is the main site of action of sugammadex
plasma
Sugammadex Dose With extreme block:
no post tetanic stimulation = 8-16mg/kg
Recurarization: not observed at appropriate doses
Reparalzation with Roc after reversal with sugammadex
5 minutes
give 1.2mg/kg
Reparalyzation with ROC after reversal with neostigmine
4 hours wait then give 0.6 mg/kg roc or 0.1 mg/kg with vec
Sugammadex Cautions
-Oral Contraceptives; Binds with Progesterone (7 days)
-Toremifene (non-steroidal anti-estrogen). Displaces NMBD from Sugammadex
-Coagulation/Bleeding; Heparin/LMWH; Elevated PTT, PT, INR
-Recurarization; than recommended doses.
Sugammadex side effects
Dose related; n/v, pruritis, urticaria
anaphylaxis
marked bradycardia
doesn’t work
S&S of recurarization
-dec 02 sats
-unresponsive patient
-appears “floppy” or uncoordinated
-ineffective abdominal and intercostal activity
sometimes can verbalize: suffocating feeling
unable to sustain head lift or hand grasp
worst case: pharyngeal collapse and respiratory obstruction
The treatment goal for recurarization
Treat urgently and aggressively
Re-sedate the patient
Give additional reversal agents in divided doses (Neostigmine 0.05 mg/kg IV = longer duration of action).
give antimuscarinic agents; Ropinirole?
First local anesthetic
cocaine
Antiarrhythmic Drug Classes:
Class I
Sodium-channel blockers.
Antiarrhythmic Drug Classes:
Class 2
Beta blockers
Antiarrhythmic Drug Classes Class 3
potassium channel blockers
Antiarrhythmic Drug Classes Class 4
CCB
Cocaine MOA
cerebral stimulating qualities
localized vasoconstriction: shrink nasal mucosa
1st synthetic ester
procaine
The standard to which all other local anesthetics are compared.
lidocaine; the first synthetic amide
LA molecular structure
Has a lipophilic portion connected by a hydrocarbon chain to the hydrophilic portion.
Bond between lipophilic and hydrocarbon classifies LA as ester or amide
Lidocaine IV dose
1 to 2 mg/kg IV (initial bolus) over 2 - 4 min.
1 to 2 mg/kg/hour (drip)
terminated 12 - 72 hours
Careful monitoring: cardiac, hepatic, renal dysfunction
Ester or amide determination is based on which portion of the LA structure?
the link between the lipophilic aromatic and hydrocarbon intermediate chain
Ph for LA
pH 6 (HCl salt): Weak Bases
Composition of LA
Epinephrine
Sodium Bisulfite
weak bases
onset procaine
slow
onset chloropocaine
rapid
tetracaine onset
slow
amides onset
all are slow except lidocaine is rapid
Duration of infiltration procaine
45-60 min
Duration of infiltration chloroprocaine
30-45 min
Duration of infiltration tetracaine
60-180 min
Duration of infiltration of lidocaine
60-120 min
Duration of infiltration prilocaine
60-120 min
Duration of infiltration mepivacaine
90-180 min
Duration of infiltration bupivicaine
240-480 min
Duration of infiltration levobupivicaine
240-480 min
Duration of infiltration ropivacaine
240 - 480 min
Procaine potency
1
chloroprocaine potency
4
tetracaine potency
16
amides potency
1; lido, prolocaine, mepivacaine
4; bupivacaine, levobupivacaine, ropivacaine
procaine pK
8.9
chloroprocaine pk
8.7
Tetracaine pk
8.5
lidocaine pK
7.9
prilocaine pK
7.9
mepivacaine pK
7.6
Bupivacaine pK
8.1
levobuvicaine pk
8.1
probivacaine pK
8.1
procaine lipid solubility
0.6
Tetracaine lipid solubility
80
lidocaine lipid solbuility
2.9
Prilocaine lipid solubilty
0.9
mepivacaine lipid solubility
1
bupivacaine lipid solubility
28
The closer the meds pK is to physiologic ph……
closer to physiologic = faster the onset of action
Lidocaine, tetracaine, and bupivacaine
have what to help prolong the DOA
miltivesicular liposomes upload higher amount of LA into a molecule & have a consistent release of LA in the tissues
Prolonged duration of action & decreased toxicity.
pubivacaine ER; up to 96 hours
LA MOA
-Binds to voltage-gated Na+ channels
-Block/inhibit Na+ passage in nerve membranes
-Slowed rate of depolarization
-Does not reach threshold
-No action potential
LA form for lipid solubility
nonionized = crosses to inside of cell and block na gate.
factors affecting blockade:
- Lipid solubility or non-ionized/unionized form
- Repetitively stimulated nerve
- Diameter of the nerve
LA in an acidic environment
becomes ionized, when ionized = won’t go through cell membrane and won’t block na gated channel.
Other Site of Action Targets of LA
Potassium channels
Calcium Ion Channels
G protein-coupled receptors
What component of the LA is required for a conduction block
non- ionized form
Minimal effective concentration
At least 2, preferably 3 Nodes of Ranvier (1 cm) blocked = 1 MAC
to prevent the propagation from being interpreted by the sc/ brain
Fastest fibers
Preganglionic B fibers - sns
Myelinated fibers speed
Myelinated A (medium) and B fibers (faster) > Unmyelinated C fibers (small)
touch/pressure, proprioception, & motor fibers
unmyelinated C fibers
fibers used for Pain & Temperature
myelinated A-δ
Pregnancy with LA
increased sensitivity
Last features to be blocked
proprioception, & motor
Weak bases with pKa values above physiologic pH……
Only 50% in lipid-soluble nonionized form
pKa’s closest to physiologic pH =
most rapid OOA
Intrinsic vasodilator activity reflects its
potency and DOA
increased vasodilation= decreased potency and DOA
Factors that influence absorption
Site of injection
Dosage
Use of Epinephrine
Pharmacologic characteristics of the drug
Lowest to highest blood concentration
SubQ
Sciatic
Brachial
Epidural
Paracervical
Caudal
tracheal
Intracenous
Epi effects on DOA
prolonged duration of action by 1/3/ limits systemic absorption by 1/3
primary determinant of potency
Lipid solubility is the primary determinant of potency
rate of tissue distribution; moa
Rate of clearance dependent on
1) Cardiac output
2) Protein binding: % bound is inversely related to % plasma
Procaine protein binding
6%